Royal London Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.98M | Sell |
144,232
-16,035
| -10% | -$442K | 0.01% | 566 |
|
|
2025
Q1 | $4.54M | Sell |
160,267
-361
| -0.2% | -$10.2K | 0.01% | 569 |
|
|
2024
Q4 | $6.68M | Sell |
160,628
-178,991
| -53% | -$7.44M | 0.02% | 506 |
|
|
2024
Q3 | $22.7M | Buy |
339,619
+4,310
| +1% | +$288K | 0.06% | 274 |
|
|
2024
Q2 | $39.8M | Sell |
335,309
-51,219
| -13% | -$6.08M | 0.1% | 167 |
|
|
2024
Q1 | $41.2M | Buy |
386,528
+18,913
| +5% | +$2.02M | 0.1% | 167 |
|
|
2023
Q4 | $36.6M | Buy |
367,615
+8,542
| +2% | +$850K | 0.1% | 169 |
|
|
2023
Q3 | $37.1M | Sell |
359,073
-32,146
| -8% | -$3.32M | 0.12% | 144 |
|
|
2023
Q2 | $47.5M | Sell |
391,219
-18,971
| -5% | -$2.31M | 0.15% | 120 |
|
|
2023
Q1 | $63M | Buy |
410,190
+147,774
| +56% | +$22.7M | 0.25% | 79 |
|
|
2022
Q4 | $47.1M | Buy |
262,416
+64,352
| +32% | +$11.6M | 0.21% | 95 |
|
|
2022
Q3 | $23.4M | Buy |
198,064
+21,337
| +12% | +$2.52M | 0.12% | 156 |
|
|
2022
Q2 | $25.2M | Buy |
176,727
+692
| +0.4% | +$98.9K | 0.12% | 159 |
|
|
2022
Q1 | $30.3M | Buy |
176,035
+5,699
| +3% | +$982K | 0.12% | 156 |
|
|
2021
Q4 | $43.3M | Buy |
170,336
+50,701
| +42% | +$12.9M | 0.16% | 119 |
|
|
2021
Q3 | $46.1M | Sell |
119,635
-2,099
| -2% | -$808K | 0.19% | 106 |
|
|
2021
Q2 | $28.6M | Buy |
121,734
+15,022
| +14% | +$3.53M | 0.12% | 157 |
|
|
2021
Q1 | $14M | Buy |
106,712
+2,557
| +2% | +$335K | 0.06% | 249 |
|
|
2020
Q4 | $10.9M | Sell |
104,155
-3,099
| -3% | -$323K | 0.06% | 274 |
|
|
2020
Q3 | $7.56M | Buy |
+107,254
| New | +$7.56M | 0.05% | 307 |
|